NeuroSigma Announces HSA Approval of the Monarch eTNS System in Singapore
October 03, 2023 09:00 ET
|
NeuroSigma, Inc.
LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced approval of the Monarch eTNS System by Singapore’s Health Sciences Authority (HSA), the national body that regulates medical...
GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression
September 29, 2023 16:45 ET
|
GH Research PLC
DUBLIN, Ireland, Sept. 29, 2023 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 23, 2023 07:00 ET
|
GH Research PLC
DUBLIN, Ireland, Aug. 23, 2023 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening
August 08, 2023 08:00 ET
|
Incannex Healthcare
Highlights: Incannex subsidiary, Clarion Clinics Group Pty Ltd (Clarion) begins accepting registrations of interest in its psychedelic-assisted therapy (PAT) treatments ahead of planned Q3...
The Future of Global Mental Health Management Research Report 2023: Complementing Prescription Therapies with AI/ML/VR for Better Outcomes to Become More Prominent
July 20, 2023 05:38 ET
|
Research and Markets
Dublin, July 20, 2023 (GLOBE NEWSWIRE) -- The "The Future of Mental Health Management" report has been added to ResearchAndMarkets.com's offering. This report identifies the challenges, drivers,...
Circular Genomics Announces Two Significant Steps Forward in Linking CircRNA to the Detection, Therapy Selection and Monitoring of Depressive Conditions
July 11, 2023 14:32 ET
|
Circular Genomics
Albuquerque, NM, July 11, 2023 (GLOBE NEWSWIRE) -- Circular Genomics, the global leader in the use of circular RNA (circRNA) biomarkers for precision psychiatry, today announced the results of a new...
Circular Genomics Announces Two Significant Steps Forward in Linking CircRNA to the Detection, Therapy Selection and Monitoring of Depressive Conditions
July 11, 2023 14:00 ET
|
Circular Genomics
Albuquerque, NM, July 11, 2023 (GLOBE NEWSWIRE) -- Circular Genomics, the global leader in the use of circular RNA (circRNA) biomarkers for precision psychiatry, today announced the results of a new...
Advanced FDA Cleared Magstim Horizon 3.0 Transcranial Magnetic Stimulation Now Available in United Kingdom
July 07, 2023 07:09 ET
|
Magstim EGI
WHITLAND, United Kingdom, July 07, 2023 (GLOBE NEWSWIRE) -- The advanced and FDA-cleared Magstim Horizon 3.0 transcranial magnetic stimulation (TMS) system is now UKCA registered and available for...
New Study into Online Gambling Finds Link between Health Conditions and Excessive Screen Time
June 14, 2023 06:36 ET
|
Minimum Deposit Casinos
LONDON, June 14, 2023 (GLOBE NEWSWIRE) -- Leading iGaming brand, Minimum Deposit Casinos (MDC), has carried out a month-long comprehensive study analysing health concerns linked to online gambling...
Leading Expert Shares Tips for Summertime Body Image and Anxiety Concerns
June 07, 2023 11:11 ET
|
Timberline Knolls
Chicago, June 07, 2023 (GLOBE NEWSWIRE) -- Warmer weather often means a focus on diets and weight loss as well as less clothing and a more exposed body. This focus can bring about body image...